NASDAQ$BTMD

biote Corp · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Briefing

biote Corp reported its financial results for the second quarter ended June 30, 2025.

The company generated total revenue of $48.9 million in Q2 2025, reflecting a slight decline from the prior year. Net income reached $3.9 million with operating income of $10.8 million, driven by cost reductions in product revenue.

  • Total revenue was $48.9 million, down 0.6% year-over-year primarily due to lower pellet procedure volumes.
  • Net income turned positive at $3.9 million compared to a loss in Q2 2024.
  • Income from operations increased to $10.8 million, supported by lower cost of revenue.
  • Cash and cash equivalents stood at $19.6 million as of June 30, 2025.

Headline financials

Total Revenue

$48.9M

Previous: $49.2M-0.6%
EPS (adj)

$0.10

Previous: -$0.19+152.6%
Capital Expenditures

-$3.44M

Previous: -$3.21M-7.1%
Net Income

$3.19M

Previous: -$6.32M+150.4%
Operating Income

$10.8M

Previous: $6.23M+72.7%
Gross Profit

-$13.9M

Previous: -$15.3M+9.2%
Cash & Equivalents

$19.6M

Previous: $26.4M-25.8%
Total Assets

$105M

Previous: $92.9M+12.8%

Revenue & EPS history

biote · Revenue · Quarterly

$48.9M

Q2 2025-0.6%vs Q2 2024
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

biote · $46M total across 2 segments · Q2 2025

  • Pellet procedures
    $35.2M
  • Dietary supplements
    $10.7M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports

Historical avg

-2.4%

Avg return

Earnings day

-4.0%

Avg return

5 days after

-3.0%

Avg return

30 days after

55%

11 / 20 earnings

Positive

+16.9%

Q3 2024

Best reaction

-25.1%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026+0.9%-9.6%+4.6%
Q4 2025-10.5%-20.9%-7.6%
Q3 2025-2.4%-11.1%-13.0%
Q1 2025+11.3%+17.1%+14.7%
Q4 2024-25.1%-0.7%-11.0%
Q3 2024+16.9%-6.3%+13.7%
Q2 2024-21.2%-17.8%-10.6%
Q1 2024+0.2%+1.0%+11.1%
Q4 2023+11.9%+27.0%+10.1%
Q3 2023-20.2%-18.4%-0.9%
Q2 2023-14.4%-22.0%-23.7%
Q1 2023-17.2%-14.3%-20.6%
Q4 2022+16.6%+34.9%+33.3%
Q3 2022+2.3%+2.5%+7.2%
Q2 2022+1.1%-4.6%-7.4%
Q1 2022+0.6%-36.9%-64.3%
Q4 2021+0.0%+0.0%+0.6%
Q3 2021-0.1%+0.1%+1.0%
Q2 2021+0.0%-0.5%-0.2%
Q1 2021+0.6%+0.6%+3.0%
Q4 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro